Rockwell Medical amends asset purchase deal with Evoqua; affirms 2024 gross margin guidance of 14-16%

ROCKWELL MEDICAL, INC.

Amendment reduces First Deferred Payment by $322,260 to $2,177,740, payable in four quarterly installments through April 2025.
Second Deferred Payment of $2.5M payable in four quarterly installments from July 2025 to April 2026.
CEO reaffirmed 2024 non-GAAP gross margin guidance of 14-16% at HC Wainwright conference, correcting a prior misstatement of 13-15% that referred to gross profit dollars.
Amendment clarifies undeliverable equipment is excluded from acquired assets and includes a release of claims related to expired inventory disposal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.